BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22201186)

  • 1. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
    Marchand B; Tremblay I; Cagnol S; Boucher MJ
    Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.
    Marchand B; Arsenault D; Raymond-Fleury A; Boisvert FM; Boucher MJ
    J Biol Chem; 2015 Feb; 290(9):5592-605. PubMed ID: 25561726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3.
    Nuutinen U; Ropponen A; Suoranta S; Eeva J; Eray M; Pellinen R; Wahlfors J; Pelkonen J
    Leuk Res; 2009 Dec; 33(12):1714-7. PubMed ID: 19559478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells.
    Enguita M; DeGregorio-Rocasolano N; Abad A; Trullas R
    Mol Pharmacol; 2005 Apr; 67(4):1237-46. PubMed ID: 15630079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
    Xia S; Li Y; Rosen EM; Laterra J
    Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
    Watcharasit P; Thiantanawat A; Satayavivad J
    J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional and post-translational regulation of Bim is essential for TGF-β and TNF-α-induced apoptosis of gastric cancer cell.
    Ha Thi HT; Lim HS; Kim J; Kim YM; Kim HY; Hong S
    Biochim Biophys Acta; 2013 Jun; 1830(6):3584-92. PubMed ID: 23500081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death.
    Yao M; Nguyen TV; Pike CJ
    J Neurosci; 2007 Feb; 27(6):1422-33. PubMed ID: 17287517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells.
    Ju Y; Xu T; Zhang H; Yu A
    Int J Oncol; 2014 Apr; 44(4):1284-92. PubMed ID: 24452601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
    Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
    Spokoini R; Kfir-Erenfeld S; Yefenof E; Sionov RV
    Mol Endocrinol; 2010 Jun; 24(6):1136-50. PubMed ID: 20371704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
    Lakshmanan J; Zhang B; Nweze IC; Du Y; Harbrecht BG
    J Cell Biochem; 2015 Jan; 116(1):133-41. PubMed ID: 25160751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel.
    Sidler D; Brockmann A; Mueller J; Nachbur U; Corazza N; Renzulli P; Hemphill A; Brunner T
    Oncogene; 2012 Sep; 31(37):4095-106. PubMed ID: 22158036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinase - c-Jun pathway transactivates Bim to promote osteoarthritis.
    Ye Z; Chen Y; Zhang R; Dai H; Zeng C; Zeng H; Feng H; Du G; Fang H; Cai D
    Can J Physiol Pharmacol; 2014 Feb; 92(2):132-9. PubMed ID: 24502636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells.
    Zhu BK; Wang P; Zhang XD; Jiang CC; Chen LH; Avery-Kiejda KA; Watts R; Hersey P
    Anticancer Drugs; 2008 Feb; 19(2):189-200. PubMed ID: 18176116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.
    Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y
    Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
    Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
    Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
    Moon DO; Lee KJ; Choi YH; Kim GY
    Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.